helped develop the study style and participated in writing and editing the manuscript. allows bacteria, toxins, undigested dietary proteins, and additional antigens to pass into the lumen, therefore increasing the number of inflammatory reactions and the activation of immune cells throughout the body. In this study, we investigate the relationship between zonulin/occludin antibodies, which are used to determine intestinal permeability, with autoantibodies used to diagnose autoimmunity. Our investigation may determine significant levels of circulating autoantibodies in human being subjects with intestinal permeability compared to those without intestinal permeability. Furthermore, we recognized that significant positive linear correlations between serum occludin/zonulin antibodies and circulating autoantibodies could be used to determine autoimmune diseases. Keywords: intestinal permeability, zonulin, autoimmunity, zonulin/occludin antibodies, leaky gut 1. Intro The worldwide incidence and prevalence of virtually all autoimmune diseases has risen continuously over the past 30 years [1]. There is growing evidence the imbalances in the gut microbiota and impaired integrity of intestinal limited junctions may play a role in the development of autoimmune disease [2,3]. In the intestinal permeability model of autoimmune disease, the breakdown of the intestinal limited junctions allows bacteria, toxins, undigested diet proteins, and additional antigens to pass into the lumen, therefore increasing inflammatory reactions within the gastrointestinal environment and throughout the body [4,5]. The loss of appropriate macromolecule trafficking can induce immune dysregulation, impair tolerance, and lead to several mechanisms that arranged the stage for the manifestation of autoimmune diseases in susceptible individuals [6,7]. The intestinal epithelium maintains its impermeability from large undigested protein macromolecules and various pathogens with occludin junctional adhesion molecules. These tight junction proteins are controlled by zonulin. Intestinal cells synthesize zonulin, which is used to reversibly regulate intestinal permeability [8]. Serum antibodies against intestinal limited junction proteins, zonulin, and occludin develop with intestinal permeability and are found to be reliable, stable, and reproducible biomarkers for identifying intestinal permeability (Number 1) [9,10]. Open in a separate window Number 1 Intestinal permeability referred to as leaky gut pathophysiology and the formation of occludin/zonulin antibodies. With this study, our objective was to assess the relationship of autoantibody markers of autoimmunity with intestinal permeability as clinically determined by the presence of elevated zonulin/occludin antibodies. This includes comparing mean autoantibodies in human being subjects with and without intestinal permeability and comparing autoimmunity risk for human being subjects with and without intestinal permeability. 2. Results There were statistically significant elevations in imply autoimmune antibodies in subjects NADP with intestinal permeability (zonulin/occludin positive) as compared to subjects without intestinal permeability (zonulin/occludin bad) for 17 out of 24 autoimmune target proteins (Number 2, Number 3, Number 4, Number 5 and Number 6). With logistic regression analyses, there was a 3- to 30-fold increase in the odds of detecting elevated autoimmune target protein antibodies in subjects Rabbit Polyclonal to MCPH1 with intestinal permeability compared to the odds of developing autoimmune target proteins in subjects without intestinal permeability (Table 1). There were also statistically significant positive linear correlations with zonulin/occludin antibodies and autoimmune target protein antibodies (Number 7, Number 8, Number 9, Number 10 and Number 11). The correlations coefficients were small to moderate (Table 2). Open in a separate window Number 2 Assessment of subjects with positive and negative serum zonulin/occludin antibody levels and neurological cells antibodies; (A) myelin fundamental protein, (B) asialoganglioside, (C) alpha/beta tubulin, (D) cerebellum, and (E) synapsin. Positive zonulin/occludin antibodies were defined as levels greater than two (2) standard deviations from your mean. The p-value for those comparisons were <0.0001. Open in a separate window Number NADP 3 Assessment of subjects with positive and negative zonulin/occludin antibody levels and various joint cells antibodies: (A) fibulin, (B) arthritic peptide, and (C) osteocyte. Positive zonulin/occludin antibodies were defined as levels greater than two (2) standard deviations from your mean. The p-ideals for those comparisons were <0.0001. Open in a separate window Number 4 Assessment of subjects with positive and negative zonulin/occludin antibody levels and endocrine cells antibodies: (A) thyroglobulin, (B) 21-hydroxylase, (C) ovary/testis, and (D) insulin/islet cell. Positive zonulin/occludin antibodies were defined as levels greater than two (2) standard NADP deviations from your mean. The p-ideals for those comparisons were <0.0001. Open in a separate window Number 5 Assessment of subjects with positive and negative zonulin/occludin antibody levels and intestinal cells antibodies: (A) parietal cell, (B) ASCA/ANCA, and (C) tropomyosin. Positive zonulin/occludin antibodies were defined as levels greater than two (2) standard deviations from your mean. The p-ideals.